527 results on '"McDonnell, Timothy J."'
Search Results
2. High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL
3. A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL
4. Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms
5. EZH2 expression is associated with inferior overall survival in mantle cell lymphoma
6. Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis
7. The Irish national chronic obstructive pulmonary disease quality improvement collaborative: an adaptive learning collaborative
8. Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy
9. High Metastatic Potential in Mice Inheriting a Targeted p53 Missense Mutation
10. Tumor Suppression and Apoptosis of Human Prostate Carcinoma Mediated by a Genetic Locus within Human Chromosome 10pter-q11
11. The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
12. Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
13. Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors
14. B-acute lymphoblastic leukemia/lymphoma (B-ALL) with precedent or concurrent myelodysplastic syndrome (MDS) with deletion 5q
15. Supplementary Figures 1-4 from The RB-E2F1 Pathway Regulates Autophagy
16. Data from The RB-E2F1 Pathway Regulates Autophagy
17. Regulation of Cell-Cycle and Apoptosis in Human Brain Tumors
18. High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL
19. Evaluating the Impact of Lab-Based Eligibility Criteria By Race/Ethnicity in Frontline Clinical Trials for Diffuse Large B-Cell Lymphoma (DLBCL): A LEO Cohort Analysis
20. Apoptosis and Cancer : Pathogenic and Therapeutic Implications
21. Comparison of outpatient and home‐based exercise training programmes for COPD: A systematic review and meta‐analysis
22. Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies
23. Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
24. Molecular Regulation and Therapeutic Implications of Cell Death in Prostate Cancer
25. Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases
26. HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis
27. Bcl-2: B Cell Life, Death and Neoplasia
28. The bcl-2 Oncogene: Apoptosis and Neoplasia
29. Clinical Validation of MCL35 in Mantle Cell Lymphoma Patients ≥65 Years Receiving Bendamustine-Rituximab
30. PI3 Kinase inhibition on TRAIL-induced apoptosis correlates with androgen-sensitivity and p21 expression in prostate cancer cells
31. Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma
32. The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death
33. Diagnosis to Treatment Interval (DTI) Informs Outcomes across Subtypes of Aggressive B-Cell Lymphoma
34. Real-World Impact of Differences in the World Health Organization (WHO) Classification and International Consensus Classification (ICC) Systems on the Diagnosis of Non-Hodgkin Lymphoma: An Analysis from the LEO Cohort Study
35. HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target
36. Selective inhibition of STAT3 induces apoptosis and G1 cell cycle arrest in ALK-positive anaplastic large cell lymphoma
37. GSH depletion enhances adenoviral bax-induced apoptosis in lung cancer cells
38. Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation
39. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells
40. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma
41. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
42. The function of multiple IκB : NF-κB complexes in the resistance of cancer cells to Taxol-induced apoptosis
43. Identification of Cell Cycle Regulatory Genes as Principal Targets of p53-mediated Transcriptional Repression
44. Characterization of 4 mantle cell lymphoma cell lines: establishment of an in vitro study model
45. TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2
46. Bcl-2 accelerates multistep prostate carcinogenesis in vivo
47. The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo
48. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
49. A 34-Year-Old Man With a Chylothorax and Bony Pain
50. Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.